Trade OCGN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Ocugen, Inc. (OCGN) is trading at US$1.36, up 0.74% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$471.36M. Over the past 52 weeks, OCGN has traded between US$1.01 and US$2.73. On Syfe you can trade OCGN with $0 commission and add it to your watchlist.
| Previous close | US$1.35 |
|---|---|
| Market cap | US$471.36M |
| 52-week range | US$1.01 – US$2.73 |
| Volume | 3.55M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Ocugen, Inc.
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
Year: 2014
Ocugen Signs Term Sheet to License Retinitis Pigmentosa Gene Therapy to Roots Pharmaceutical, Al-Dhow in MENA Region
Jul 13, 11:51 AM · MT Newswires
Ocugen Prices $115 Million Convertible Senior Notes Offering
May 5, 2:42 PM · MT Newswires
Sector Update: Health Care Stocks Advance Pre-Bell Wednesday
Apr 1, 1:14 PM · MT Newswires
Ocugen Completes Enrollment, Dosing for Phase 2/3 Eye Disorder Treatment Trial; Shares Up Pre-Bell
Apr 1, 11:46 AM · MT Newswires
Ocugen, Inc. (OCGN) stock is trading at US$1.36, +0.74% from the previous close of US$1.35.
The market cap for Ocugen, Inc. (OCGN) stock is approximately US$471.36M.
The 52-week high for Ocugen, Inc. (OCGN) stock is US$2.73.
The 52-week low for Ocugen, Inc. (OCGN) stock is US$1.01.
Ocugen, Inc. (OCGN) does not currently pay a dividend.
Stay on top of OCGN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
